Fig. 3From: An open label, non-controlled, multicentre, interventional trial to investigate the safety and efficacy of Canephron® N in the management of uncomplicated urinary tract infections (uUTIs)Comparison between uUTI sumscore assessed by patients and investigators. The uUTI Sumscore includes the symptoms dysuria, frequency and urgency; uUTI Sumscore was assessed on Day 0, Day 7 and Day 37 (full analysis set, N = 125)Back to article page